About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

A Phase 1, Open-Label Study to Evaluate the Effects of Food and Multiple-Doses of Esomeprazole on the Pharmacokinetics of a Single Oral Dose of LY4064809 in Healthy Adult Participants

NCT06991179•Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Healthy

Interventions

LY4064809

Locations

1

United States

Locations (1)

Pharmaron Clinical Pharmacology Center Inc

Baltimore, Maryland, United States

Key Dates

Start Date

May 20, 2025

Primary Completion Date

September 2, 2025

Completion Date

September 2, 2025

Last Updated

September 23, 2025

Related Studies

RECRUITINGPhase 1/2

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

NCT06290258

Autism Spectrum DisorderGastrointestinal Diseases+1 more

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT00090662

Healthy Volunteer

A New Portable Device for Non-invasive Ventilatory Support

NCT06716502

HealthyRespiratory Disease

RECRUITINGPhase 1

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool

NCT07483606

Healthy Adult ParticipantsToxic Chemicals+1 more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713

Healthy ParticipantsHealthy Subjects+5 more

View all related studies

Sponsors

Lead Sponsor

Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 23, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions